Korea Developed 1st COVID 19 Vaccine with Blood Plasma Donated by Shincheonji Members

As we covered in this blog, during the COVID 19 pandemic, despite the harsh persecution of Korean society towards the Shincheonji Church of Jesus, over 4,000 members of Shincheonji donated their blood plasma after being healed from COVID 19. Back then, the Korean government blamed the Shincheonji Church of Jesus for spreading COVID 19. For them, it must be a tough time for being exposed to nation-level hate crimes. Government, local governments, and even the press tried to get rid of the church for spreading COVID 19. Even so, the Chairman of Shincheonji Church of Jesus, Lee Man Hee, encouraged Shincheonji members to donate their blood plasma after curing COVID 19. He said that he wishes this activity could help develop a cure for COVID 19. When the whole country persecuted them to death (literally, several members were killed by hate crimes) they wanted to help the country.

That was around December 2020. After two and a half years, the first Korean COVID 19 vaccine was developed thanks to the blood plasma donation of Shincheonji members. Here’s an English article about this: http://noahbrown1984.blogspot.com/2022/07/the-development-of-coronavirus-vaccine.html

Skycobi One vaccine was developed by SK Bioscience Korea.

Professor Woo-joo Kim of the Division of Infectious Diseases at Korea University Guro Hospital, president of the Korean Vaccine Society, said, “The birth of the first vaccine is truly a ‘miracle.’ What was supposed to cost billions of dollars over 10 years was accomplished in two and a half years.”

This vaccine, ‘Skycobi One Multi Injection (GBP510)’, was approved by the Ministry of Food and Drug Safety (MFDS). Korea Disease Control and Prevention Agency (KCDC) stated that development would not have been possible without members of Shincheonji Church of Jesus, who was responsible for more than 90% of donated blood plasma. “Thanks to those who actively donated plasma, we were able to make the national standard material, which was invaluable in evaluating the efficiency of samples in domestic COVID 19 vaccine clinical trials,” said Jun-woo Lee, a researcher at the National Institute of Health and Care Research of the Korean Center for Disease Control.

COVID 19 virus occurs in various variants such as Omicron, Stealth Omicron, BA.4, BA.5, and the centaur (BA2.75) variants. Skycobi One vaccine is expected to be effective against these variants as the Omicron variant immune response is confirmed when it receives the booster shot.

I’m glad to hear that the new vaccine that was developed in Korea will be effective also for the variants of COVID 19. This could happen thanks to Shincheonji members’ mass blood plasma donation. It reminds me of Jesus shedding his noble blood to save people’s lives. Like so, Shincheonji members shared blood plasma to save people’s lives. Their noble deeds should be officially appreciated and remembered. Thank you, Shincheonji members!

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s